Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

Share Price is delayed by 15 minutes
Get Live Data
0.50    0.00 (0.00%)
Bid:
0.45
Ask:
0.55
Spread: 0.10 (22.222%)
Market Cap: £4.66m
SUN Live PriceLast checked at - London Stock Exchange

Intraday Surgical Innovations Share Chart

Re: US contract and FDA approval

1 Feb 2012 07:00

RNS Number : 5499W
Surgical Innovations Group PLC
01 February 2012
 



For immediate release

1 February 2012

 

Surgical Innovations Group plc

("SI" or "the Group")

FDA Approval for Logic™ reusable instrument range

US contract with Premier healthcare alliance

 

Surgical Innovations Group plc (AIM:SUN), the designer and manufacturer of creative solutions for minimally invasive surgery, is pleased to announce that it is has received 510(k) clearance from the US Food and Drug Administration ("FDA") for its Logic™ range of reusable instruments and permits the use of the range in the US market.

The instruments are compatible with the Group's Logic™ Handles, which already have approval in the US, and are currently used with SI's Resposable™ Logi™Range.

Graham Bowland, Chief Executive Officer of the Group, said: "We are delighted to announce the FDA approval of our reusable instruments in the US. The economic drivers away from single use instruments in the US are clear, and our modular instruments are ideally positioned to satisfy current surgical procedure budgets."

The Group is also pleased to announce that its US master dealer, SI USA Inc., has been awarded a contract by the Premier healthcare alliance for the sale of the Group's Resposable™ Logi™Range, and Logic™ range of reusable instruments. The contract will run from 1 April 2012 for three years, with the option to extend a further two years upon the agreement of both parties.

The contract will provide SI with additional access to hospitals and hospital networks across the US, and replaces previous, but more limited, contracts already held with Premier.

Graham Bowland continued: "This latest contract with Premier provides us with much more flexibility in the products we can offer whilst giving us access to hospitals that we were previously unable to approach. This is a very exciting development for the Group and strengthens our position in our largest target market."

 

For further enquiries:

Surgical Innovations Group plcDoug Liversidge, ChairmanGraham Bowland, Chief Executive Officer +44 (0)113 230 7597

Seymour Pierce Limited

Freddy Crossley/ Sarah Jacobs Tel: +44 (0) 20 7107 8000

Corporate Broking

David Banks / Jacqui Briscoe www.seymourpierce.com

The Communications PortfolioAriane Comstive / Caolan Mahon +44 (0) 20 7536 2028 / 2029

 

 

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery (MIS) and industrial markets.

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

Over 140 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

The Group's patented products are sold through three main channels:

SI brand

Through an established network of 45 distribution partners, Surgical Innovations branded products are sold in all major medical markets including North America, Europe, South Africa, the Middle East, South-east Asia and Australia.

OEM and IP

The Group supplies large medical device companies on an OEM basis, collecting both sales and IP royalty fees. Clients include Teleflex Medical, Olympus, Gyrus and CareFusion.

Industrial

 

SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime.

For more information, see www.sigroupplc.com

 

About the Premier healthcare alliance,

 

Premier is a performance improvement alliance of more than 2,500 U.S. hospitals and 80,000-plus other healthcare sites using the power of collaboration to lead the transformation to high quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier has worked with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has an office in Washington.

 

For more information, see http://www.premierinc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKDDQKBKBFDN
Date   Source Headline
7th Jul 20267:00 amRNSElemental secures MIS3 Framework
30th Jun 20261:04 pmRNSResult of AGM
15th Jun 20267:00 amRNSDirector appointment
5th Jun 20267:00 amRNSNotice of AGM & Posting of Annual Report &Accounts
21st Apr 20267:00 amRNSFinal Results
9th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Jan 20267:00 amRNSChief Financial Officer update
18th Dec 20257:00 amRNSTrading Update
28th Nov 20257:00 amRNSNew LTIP & Grant of Options
29th Sep 20257:05 amRNSBoard Changes
29th Sep 20257:00 amRNSHalf-year Report
17th Sep 20253:15 pmRNSNotice of Results
27th Jun 20254:42 pmRNSResult of AGM
26th Jun 202511:36 amRNSWithdrawal of AGM Resolutions 9 and 10
4th Jun 20258:00 amRNSNotice of AGM & Posting of Annual Report &Accounts
30th May 20257:00 amRNSFinal Results
10th Apr 20257:00 amRNSTrading update
1st Apr 202511:30 amRNSUpdate on timing of 2024 Full Year results
19th Feb 202510:11 amRNSHolding(s) in Company
17th Feb 20254:12 pmRNSHolding(s) in Company
12th Feb 20257:00 amRNSFY24 Trading Update & & Directorship Change
30th Sep 20247:00 amRNSHalf-year Report
10th Sep 20247:00 amRNSNotice of Results
27th Aug 20243:51 pmRNSHolding(s) in Company
27th Aug 20243:49 pmRNSHolding(s) in Company
19th Aug 20241:06 pmRNSHolding(s) in Company
19th Aug 20241:01 pmRNSHolding(s) in Company
29th Jul 202412:18 pmRNSHolding(s) in Company
25th Jul 20244:04 pmRNSHolding(s) in Company
17th Jun 20244:43 pmRNSResult of AGM
10th Jun 20247:00 amRNSDirectorate Change - Appointment of CFO
23rd May 20247:00 amRNSNotice of AGM and Posting of Annual Report
22nd Apr 20243:34 pmRNSHolding(s) in Company
19th Apr 20246:25 pmRNSHolding(s) in Company
18th Apr 20247:01 amRNSFinal Results
18th Apr 20247:00 amRNSNew exclusive UK distribution agreements secured
9th Apr 20247:00 amRNSDirectorate Change & Notice of Results
29th Jan 20247:00 amRNSYear-end 2023 Trading Update
19th Dec 20237:00 amRNSDirectorate Change
5th Dec 20237:00 amRNSDirectorate Change
19th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSTrading Update and Notice of Results
27th Jun 202312:12 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement
26th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
25th May 202311:11 amRNSDirector/PDMR Shareholding - Replacement
25th May 20237:00 amRNSDirector/PDMR Shareholding
22nd May 20237:00 amRNSDirectorate changes and board succession planning
29th Mar 20237:00 amRNSFinal Results
3rd Mar 20237:00 amRNSNotice of Results and Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.